the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Only 2.8 per cent of 730 Work Ministry’s projects in 2023 considered “sick”

KUALA LUMPUR: A total of 182 projects, worth RM4.63 billion, carried out under the Works Ministry (KKR) have been completed, said Public Works Minister Datuk Seri Alexander Nanta Linggi.

He said only 21 projects or 2.8 per cent of the 730 projects under construction in 2023 were classified as sick projects.

“The number of sick projects is small compared to the projects that are active and have been completed. JKR is always monitoring these sick projects and taking intervention measures to save them,“ he said when winding up the debate on the Motion to Thaks for the Royal Address on behalf of the ministry in the Dewan Rakyat today.

Meanwhile, Nanta said the ministry had received a total of 12,245 complaints through the MYJalan application regarding damage to roads, traffic lights and street lights, signboards, street furniture and other public facilities.

However, only 25.91 per cent or 3,173 complaints involved roads under the ministry’s supervision, he added.

“A total of 2,345 complaints have been resolved with 2,193 or 93.52 per cent resolved within one to 30 days,” he said.

According to Nanta, the Work Ministry also aims to add 79 more shaded areas for motorcyclists on the highway this year.

“This brings to a total of 119 motorcycle shelter locations built under the initiative of KKR, Malaysian Highways Authority (LLM) and concession companies throughout 2023-2024 in addition to the existing 353 motorcycle shelters along the highway,“ he said.-Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings